Vision RT AlignRT GateCT GateRT Motion Management Solution ASTRO 2014

September 10, 2014 — Vision RT announced that it will use its exhibit at this year’s American Society for Radiation Oncology (ASTRO) meeting in San Francisco to highlight its cutting-edge optical guidance technology.

At booth 2408 in the exhibition hall, ASTRO attendees will be able to see demonstrations of the full functionality of Vision RT’s AlignRT system, including its frameless SRS module. GateCT and GateRT will also be on display, and technical and clinical support staff will be on hand to answer questions relating to Vision RT’s products.

Vision RT will also host presentations from two clinical experts who will share their experiences on the advanced use of AlignRT in their respective treatment centres. Lesley Jarvis M.D. Ph.D., attending physician at Dartmouth-Hitchcock Norris Medical Center, will discuss how users can achieve cardiac sparing and improve setup for breast treatments using AlignRT, based on its clinical use at Dartmouth-Hitchcock Norris Cotton Cancer Center in Lebanon, N.H. Michael Tallhame, MSc, DABR, chief of radiation physics at Centura Health Parker Adventist Hospital in Denver, will discuss the benefits of using AlignRT for intracranial SRS.

In addition to the presentations on the Vision RT booth there will be several oral presentations and poster publications about AlignRT during the meeting.

For more information: www.visionrt.com

Related Content

News | Prostate Cancer

August 16, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 16, 2022
arrow
News | Breast Imaging

August 15, 2022 — Brainlab announced the first group of breast cancer patients treated in United States with the ...

Time August 15, 2022
arrow
News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
News | Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

Time July 27, 2022
arrow
News | Radiation Oncology

July 25, 2022 — RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s ...

Time July 25, 2022
arrow
Subscribe Now